Avoro Capital Advisors LLC - Q1 2014 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q1 2014
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMICUS THERAPEUTICS INC.39Q2 202417.9%
MIRATI THERAPEUTICS INC.36Q4 202317.2%
BIOMARIN PHARMACEUTICAL INC34Q2 20248.0%
SAREPTA THERAPUTICS INC31Q2 202414.8%
ASCENDIS PHARMA31Q2 20249.1%
ARGENX SE29Q2 20249.5%
IOVANCE BIOTHERAPEUTICS INC29Q2 20249.1%
FENNEC PHARMACEUTICALS INC26Q4 20230.4%
MADRIGAL PHARMACEUTICALS INC25Q2 20247.7%
XENON PHARMACEUTICALS INC25Q2 20243.6%

View Avoro Capital Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Avoro Capital Advisors LLC Q1 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Spyre Therapeutics, Inc.April 23, 20241,839,1385.1%
AMICUS THERAPEUTICS, INC.February 14, 202427,400,0009.3%
Apellis Pharmaceuticals, Inc.February 14, 202413,411,1119.9%
Ascendis Pharma A/SFebruary 14, 20243,755,5556.5%
BIOCRYST PHARMACEUTICALS INCFebruary 14, 202413,050,0006.4%
CymaBay Therapeutics, Inc.February 14, 202416,337,73910.0%
IO Biotech, Inc.Sold outFebruary 14, 202400.0%
Krystal Biotech, Inc.February 14, 20242,565,5559.1%
Kymera Therapeutics, Inc.February 14, 20243,775,0006.8%
MADRIGAL PHARMACEUTICALS, INC.February 14, 20242,288,8889.9%

View Avoro Capital Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-14
42024-06-14
13F-HR2024-05-15
SC 13G/A2024-04-23
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Avoro Capital Advisors LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Avoro Capital Advisors LLC's holdings

CSVXLS